In vivo prophylactic activity of QR-435 against H3N2 influenza virus infection.

MLA

Oxford, John S., et al. “In Vivo Prophylactic Activity of QR-435 against H3N2 Influenza Virus Infection.” American Journal of Therapeutics, vol. 14, no. 5, Sept. 2007, pp. 462–68. EBSCOhost, https://doi.org/10.1097/MJT.0b013e3180a7206e.

APA

Oxford, J. S., Lambkin, R., Guralnik, M., Rosenbloom, R. A., Petteruti, M. P., Digian, K., & LeFante, C. (2007). In vivo prophylactic activity of QR-435 against H3N2 influenza virus infection. American Journal of Therapeutics, 14(5), 462–468. https://doi.org/10.1097/MJT.0b013e3180a7206e

Chicago

Oxford, John S, Robert Lambkin, Mario Guralnik, Richard A Rosenbloom, Michael P Petteruti, Kelly Digian, and Carolyn LeFante. 2007. “In Vivo Prophylactic Activity of QR-435 against H3N2 Influenza Virus Infection.” American Journal of Therapeutics 14 (5): 462–68. doi:10.1097/MJT.0b013e3180a7206e.